PubMed

Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.

Fichna J, Schicho R, Janecka A, Zjawiony JK, Storr M.

Drug News Perspect. 2009 Sep;22(7):383-92.PMID: 19890495 [PubMed - in process]Related articles

Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.

Adams JD Jr.

Curr Med Chem. 2009;16(27):3476-9.PMID: 19799545 [PubMed - in process]Related articles

Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.

Morani AS, Kivell B, Prisinzano TE, Schenk S.

Pharmacol Biochem Behav. 2009 Dec;94(2):244-9. Epub 2009 Sep 10.PMID: 19747933 [PubMed - in process]Related articles

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.

Simpson DS, Lovell KM, Lozama A, Han N, Day VW, Dersch CM, Rothman RB, Prisinzano TE.

Org Biomol Chem. 2009 Sep 21;7(18):3748-56. Epub 2009 Jul 14.PMID: 19707679 [PubMed - indexed for MEDLINE]Related articles

Chemical methods for the synthesis and modification of neoclerodane diterpenes.

Lozama A, Prisinzano TE.

Bioorg Med Chem Lett. 2009 Sep 15;19(18):5490-5. Epub 2009 Jul 17.PMID: 19679471 [PubMed - in process]Related articles

Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors.

Fichna J, Schicho R, Andrews CN, Bashashati M, Klompus M, McKay DM, Sharkey KA, Zjawiony JK, Janecka A, Storr MA.

Neurogastroenterol Motil. 2009 Dec;21(12):1326-e128. Epub 2009 Jul 23.PMID: 19650775 [PubMed - in process]Related articles

Neuroscience. Salvia on schedule.

Brown DJ.

Sci Am. 2009 Aug;301(2):20-1. No abstract available. PMID: 19634554 [PubMed - indexed for MEDLINE]Related articles

Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals.

Grilli M, Neri E, Zappettini S, Massa F, Bisio A, Romussi G, Marchi M, Pittaluga A.

Neuropharmacology. 2009 Oct-Nov;57(5-6):523-30. Epub 2009 Jul 21.PMID: 19628000 [PubMed - in process]Related articles

Evaluation of the Transport, In Vitro Metabolism and Pharmacokinetics of Salvinorin A, a Potent Hallucinogen.

Teksin ZS, Lee IJ, Nemieboka NN, Othman AA, Upreti VV, Hassan HE, Syed SS, Prisinzano TE, Eddington ND.

Eur J Pharm Biopharm. 2009 Jan 19. [Epub ahead of print]PMID: 19602379 [PubMed - as supplied by publisher]Related articles

Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence.

Hooker JM, Munro TA, Béguin C, Alexoff D, Shea C, Xu Y, Cohen BM.

Neuropharmacology. 2009 Sep;57(4):386-91. Epub 2009 Jul 8.PMID: 19591852 [PubMed - in process]Related articles

Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor.

Yan F, Bikbulatov RV, Mocanu V, Dicheva N, Parker CE, Wetsel WC, Mosier PD, Westkaemper RB, Allen JA, Zjawiony JK, Roth BL.

Biochemistry. 2009 Jul 28;48(29):6898-908.PMID: 19555087 [PubMed - indexed for MEDLINE]Related articles

[Simple and rapid screening for psychotropic natural products using Direct Analysis in Real Time (DART)-TOFMS]

Kawamura M, Kikura-Hanajiri R, Goda Y.

Yakugaku Zasshi. 2009 Jun;129(6):719-25. Japanese. PMID: 19483414 [PubMed - indexed for MEDLINE]Related articlesFree article

Salvinorins J from Salvia divinorum: mutarotation in the neoclerodane system.

Kutrzeba LM, Ferreira D, Zjawiony JK.

J Nat Prod. 2009 Jul;72(7):1361-3.PMID: 19473009 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen.

Teksin ZS, Lee IJ, Nemieboka NN, Othman AA, Upreti VV, Hassan HE, Syed SS, Prisinzano TE, Eddington ND.

Eur J Pharm Biopharm. 2009 Jun;72(2):471-7.PMID: 19462483 [PubMed - indexed for MEDLINE]Related articles

Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.

Braida D, Capurro V, Zani A, Rubino T, Viganò D, Parolaro D, Sala M.

Br J Pharmacol. 2009 Jul;157(5):844-53. Epub 2009 May 5.PMID: 19422370 [PubMed - indexed for MEDLINE]Related articles

Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil.

Seeman P, Guan HC, Hirbec H.

Synapse. 2009 Aug;63(8):698-704.PMID: 19391150 [PubMed - indexed for MEDLINE]Related articles

Analyzing salvia divinorum and its active ingredient salvinorin a utilizing thin layer chromatography and gas chromatography/mass spectrometry.

Jermain JD, Evans HK.

J Forensic Sci. 2009 May;54(3):612-6. Epub 2009 Feb 27.PMID: 19298461 [PubMed - indexed for MEDLINE]Related articles

In vitro stability and metabolism of salvinorin A in rat plasma.

Tsujikawa K, Kuwayama K, Miyaguchi H, Kanamori T, Iwata YT, Inoue H.

Xenobiotica. 2009 Mar 11:1-8. [Epub ahead of print]PMID: 19280383 [PubMed - as supplied by publisher]Related articles

Synthesis of deacetyl-1,10-didehydrosalvinorin G.

Ma Z, Lee DY.

Tetrahedron Lett. 2008 Mar 10;49(11):1782-1785.PMID: 19279674 [PubMed]Related articlesFree article

Total synthesis of 20-norsalvinorin A. 1. Preparation of a key intermediate.

Bergman YE, Mulder R, Perlmutter P.

J Org Chem. 2009 Mar 20;74(6):2589-91.PMID: 19231873 [PubMed - indexed for MEDLINE]Related articles